SECsense Logo

180 Life Sciences Corp. Financial Report: Key Insights for December 2024

$ATNF
Form 8-K
Filed on: 2024-12-18
Source
180 Life Sciences Corp. Financial Report: Key Insights for December 2024

The section of the financial report provides several key pieces of information regarding 180 Life Sciences Corp., identified by SEC CIK number 0001690080. Here are the most important details extracted from the report:

  1. Company Information:
  • Name: 180 Life Sciences Corp.
  • Address: 3000 El Camino Real, Building 4, Suite 200, Palo Alto, CA 94306.
  • Phone: (650) 507-0669.
  • SEC CIK: 0001690080.
  • Trading Symbols:
    • Common Stock: ATNF (NASDAQ)
    • Warrants to Purchase Shares of Common Stock: ATNFW (NASDAQ)
  1. Financial Instruments:
  • Common Stock: The par value is $0.0001 per share.
  • Warrants: There are warrants available for purchase of shares of common stock.
  1. Reporting Period:
  • The report pertains to a specific date: December 16, 2024.
  1. Units of Measurement:
  • Financial amounts are reported in USD (US Dollars).
  • Share counts are also noted, although specific quantities are not detailed in this excerpt.
  1. XBRL Tags:
  • The report utilizes XBRL (eXtensible Business Reporting Language) for data structuring, indicating compliance with SEC reporting standards.
  • It specifies dimensions related to the class of stock, which may suggest the existence of multiple classes of stock or financial instruments.
  1. Contextual Information:
  • The report includes explicit context identifiers for the financial metrics, ensuring clarity about the reporting period and the nature of the instruments.

Insights:

  • The low par value of common stock suggests the company may be in a growth phase, often a characteristic of biotech or life sciences firms.
  • The presence of warrants indicates potential dilution for existing shareholders but also suggests opportunities for raising capital in the future.
  • The report appears to be part of a larger regulatory filing (indicated by the presence of an 8-K form), which may contain additional significant disclosures regarding corporate actions or updates.

Overall, this report provides a snapshot of the company's equity structure and its compliance with necessary financial reporting standards. Further analysis would require additional financial data, such as total shares outstanding, financial performance metrics, and any accompanying notes or management discussions.